Megestrol acetate is a common and efficient anticancer progesterone. To explore the activity and the therapeutic mechanisms of megestrol acetate in endometrial cancer, human endometrial cancer cell lines Ishikawa and HHUA overexpressing progesterone receptor A (PR-A) and progesterone receptor B (PR-B) were treated with megestrol acetate. Cell viability, apoptosis, cycle arrest, and senescence, as well as the expressions of p21 and p16, two hallmarks of cellular senescence, were evaluated. Compared with the control, >10 nmol/L megestrol acetate treatment could significantly reduce endometrial cancer cell growth, and induce the irreversible G1 arrest and cell senescence. The expression of cyclin D1 in megestrol acetate treated cells was downregulated, while the expressions of p21 and p16 were upregulated via PR-B isoform. FOXO1 inhibitor AS1842856 could significantly abrogate megestrol acetate-induced cell senescence, suggesting that FOXO1 was involved in megestrol acetate/PR-B axis. These findings may provide a new understanding for the treatment of human endometrial cancer.
BuhtoiarovaTNBrennerCASinghM.Endometrial carcinoma. Am J Clin Pathol2016;
145:8–21
2.
DiCAEllensonLH.Endometrial carcinoma. Annu Rev Pathol2007;
2:57
3.
BokhmanJV.Two pathogenetic types of endometrial carcinoma. Gynecol Oncol1983;
15:10–7
4.
GompelA.Progesterone and endometrial cancer. Best Pract Res Clin Obstet Gynaecol2020;
69:95–107
5.
PratJ.Prognostic parameters of endometrial carcinoma. Hum Pathol2004;
35:649–62
6.
Matias-GuiuXPratJ.Molecular pathology of endometrial carcinoma. Histopathology2013;
62:111–23
7.
SalvesenHBAkslenLA.Molecular pathogenesis and prognostic factors in endometrial carcinoma. APMIS2002;
110:673–89
8.
CorzoCBarrientos SantillanNWestinSNRamirezPT.Updates on conservative management of endometrial cancer. J Minim Invasive Gynecol2018;
25:308–13
9.
GundersonCCFaderANCarsonKABristowRE.Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol2012;
125:477–82
10.
HuaJHanJWangXGuoYZhouB.The binary mixtures of megestrol acetate and 17α-ethynylestradiol adversely affect zebrafish reproduction. Environ Pollut2016;
213:776–84
11.
LeinungMCLiporaceRMillerCH.Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med1995;
122:843–5
12.
LoprinziCLJensenMDJiangNSSchaidDJ.Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc1992;
67:1160–2
13.
McKoneEFTonelliMRAitkenML.Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis. Pediatr Pulmonol2002;
34:381–3
14.
BodennerDLMedhiMEvansWJSullivanDHLiuHLambertCP.Effects of megestrol acetate on pituitary function and end-organ hormone secretion: a post hoc analysis of serum samples from a 12-week study in healthy older men. Am J Geriatr Pharmacother2005;
3:160–7
15.
FioricaJVBrunettoVLHanjaniPLentzSSMannelRAndersenW.Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;
92:10–4
16.
KimJJKuritaTBulunSE.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev2013;
34:130–62
17.
BellengerCRChenJC.Effect of megestrol acetate on the endometrium of the prepubertally ovariectomised kitten. Res Vet Sci1990;
48:112–8
18.
SchacterLRozencweigMCanettaRKelleySNicaiseCSmaldoneL.Megestrol acetate: clinical experience. Cancer Treat Rev1989;
16:49–63
19.
Valadez-CosmesPVazquez-MartinezERCerbonMCamacho-ArroyoI.Membrane progesterone receptors in reproduction and cancer. Mol Cell Endocrinol2016;
434:166–75
20.
VegetoEShahbazMMWenDXGoldmanMEO'MalleyBWMcDonnellDP.Human progesterone receptor a form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol1993;
7:1244–55
21.
AttiaGRZeitounKEdwardsDJohnsACarrBRBulunSE.Progesterone receptor isoform a but not B is expressed in endometriosis. J Clin Endocrinol Metab2000;
85:2897
22.
WölflerMMKüppersMRathWBuckVUMeinhold-HeerleinIClassen-LinkeI.Altered expression of progesterone receptor isoforms a and B in human eutopic endometrium in endometriosis patients. Ann Anat2016;
206:1–6
23.
SaitoTMizumotoHTanakaRSatohisaSAdachiKHorieMKudoR.Overexpressed progesterone receptor form B inhibit invasive activity suppressing matrix metalloproteinases in endometrial carcinoma cells. Cancer Lett2004;
209:237–43
24.
ZhangSZengNAlowayedNSinghYChengALangFSalkerMS.Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells. PloS One2017;
12:e0183681
25.
DeAFGuidoCSantoroMGiordanoFDonãARizzaPPellegrinoMPerrottaIBonofiglioDSisciD.Ligand activated progesterone receptor B drives autophagy-senescence transition through a beclin-1/Bcl-2 dependent mechanism in human breast cancer cells. Oncotarget2016;
7:57955–69
26.
KandothCSchultzNCherniackADAkbaniRLiuYShenHRobertsonAGPashtanIShenRBenzCCYauCLairdPWDingLZhangWMillsGBKucherlapatiRMardisERLevineDA, Cancer Genome Atlas Research N.Integrated genomic characterization of endometrial carcinoma. Nature2013;
497:67–73
27.
BinesJDienstmannRObadiaRMBrancoLGPQuintellaDCCastroTMCamachoPGSoaresFACostaMEF.Activity of megestrol acetate in postmenopausal women with advanced breast cancer after nonsteroidal aromatase inhibitor failure: a phase II trial. Ann Oncol2014;
25:831–6
28.
WilailakSLinasmitaVSrisupunditS.Phase II study of high-dose megestrol acetate in platinum-refractory epithelial ovarian cancer. Anticancer Drugs2001;
12:719–24
29.
IshiwataIUdagawaYOkumuraHNozawaS.Effects of progesterone on human endometrial carcinoma cells in vivo and in vitro. J Natl Cancer Inst1978;
60:947–54
30.
KimuraJ.Effect of progesterone on cell division in chemically induced endometrial hyperplasia and adenocarcinoma in mice. Cancer Res1978;
38:78–82
31.
SharifzadehFAminimoghaddamSKashanianMFazaeliMSheikhansariN.A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia. Gynecol Endocrinol2016;
33:152–5
32.
MyersAPFiliaciVLZhangYPearlMBehbakhtKMakkerVHanjaniPZweizigSNdBJDowneyG.Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol2016;
141:43–8
33.
PautierPVergoteIJolyFMelicharBKutarskaEHallGLisyanskayaAReedNOakninAOstapenkoV.A phase 2, randomized, open-label study of irosustat versus megestrol acetate in advanced endometrial cancer. Int J Gynecol Cancer2016;
27:258
34.
YangBYGulinaziYDuYNingCCChengYLShanWWLuoXZZhangHWZhuQMaFHLiuJSunLYuMGuanJChenXJ.Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial. BJOG2020;
127:848–57
35.
YamadaH.Suppression of tumorigenicity and induction of senescence on human endometrial carcinoma cell lines by transfer of normal human chromosomes. Hokkaido Igaku Zasshi1994;
69:1443–54
36.
AlektiarKMVenkatramanEAbu-RustumNBarakatRR.Is endometrial carcinoma intrinsically more aggressive in elderly patients?Cancer2003;
98:2368–77
37.
RicherJKJacobsenBMManningNGAbelMGWolfDMHorwitzKB.Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem2002;
277:5209–18
38.
De AmicisFGuidoCSantoroMLanzinoMPanzaSAvenaPPannoMLPerrottaIAquilaSAndòS.A novel functional interplay between progesterone receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells. J Cell Mol Med2014;
18:2252–65
39.
DiepCHCharlesNJGilksCBKallogerSEArgentaPALangeCA.Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. Cell Cycle2013;
12:1433–49
40.
DiepCHKnutsonTPLangeCA.Active FOXO1 is a key determinant of isoform-specific progesterone receptor transactivation and senescence programming. Mol Cancer Res2016;
14:141–62
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
